June 15, 2023 | By John Raslavsky | Cirrhosis, Clinical Trials, Liver Disease, Liver Health, Volunteering in Research | Cirrhosis, Clinical research, Clinical trials, Fatty Liver Disease, liver health, Liver research, Liver Scarring
Liver cirrhosis is a chronic and potentially life-threatening condition affecting many worldwide and in Arizona. Historically, men have been disproportionately affected by liver cirrhosis. Studies show that death rates amongst men with liver cirrhosis are twice as high as women. …
January 9, 2023 | By John Raslavsky | Liver, Liver Health | 2023, Arizona, Blog, Clinical research, Liver awareness, Liver research, New year new liver health
The new year is here, and the promise of more liver research comes with it. The more we understand the liver, the better we can treat its issues. From participating in clinical trials to simply raising awareness, there’s something everyone …
October 14, 2022 | By John Raslavsky | Liver Disease, Liver Health | Blog, Clinical research, Fatty Liver Disease, Liver research
Worldwide, liver cancer is the second most common cause of cancer-related death. Yet, with such prevalence, it remains challenging to treat. As numbers continue to rise, the value of liver research is critical to public health. Learn more about …
September 15, 2022 | By John Raslavsky | Liver Health, News & Events | Blog, Clinical research, Fibroscan, liver health, Liver research, NASH, NASH Complications
Many medical conditions like diabetes can lead to other potential health concerns. Read our blog to learn more about the correlation between diabetes and nonalcoholic steatohepatitis (NASH). The Relationship Between Diabetes and NASH Those living with diabetes are more likely to …
July 1, 2022 | By John Raslavsky | Cirrhosis, Clinical Research, NASH | Blog, Clinical trials, Fatty Liver Disease, liver health, Liver research
At their very root, non-alcoholic steatohepatitis (NASH) and cirrhosis are two medical conditions that affect the liver. However, this seemingly separate duo shares more in common than you may think. When NASH and cirrhosis get together, your liver is at …
June 8, 2022 | By John Raslavsky | Clinical Research, Hepatitis B | Blog, Clinical trials, liver health, Liver research
Like many other liver diseases, hepatitis B is a “silent epidemic” because most people do not have symptoms for most of the disease progression. It is one of the most common serious liver infections globally and in the state of …
May 31, 2022 | By John Raslavsky | Clinical Research, Jaundice, NASH | bilirubin and liver function, Blog, Clinical trials, Liver research, NASH Complications
Jaundice is a yellowing of the eye sclera (the white part) and skin because there’s too much bilirubin in the blood. There are many causes of jaundice. However, for people living with liver disease, jaundice is a common nonalcoholic steatohepatitis …
May 11, 2022 | By John Raslavsky | Clinical Research, Hepatitis C | Blog, Clinical trials, Liver research, NASH
Hepatitis C is a liver infection from the hepatitis C virus (HCV). For some people, HCV causes short-term illness. However, for more than half, it becomes a long-term, chronic infection that can result in severe and life-threatening health problems. Liver …
March 30, 2022 | By John Raslavsky | Clinical Research, Hepatitis | Blog, Clinical trials, Fatty Liver Disease, liver health, Liver research, NAFLD, NASH
Liver health is essential to the function of the human body. It performs over 500 functions to keep the body healthy. A few examples are flushing out toxins, processing food, and maintaining healthy blood sugar levels. Hepatitis is one of …
February 14, 2022 | By John Raslavsky | Clinical Research, Liver Health | American heart month, Blog, Clinical trials, heart-liver connection, Liver research
When we think of hearts, we think of Valentine’s Day and the exchange of cards and unique trinkets shared with our family and friends. February is also American Heart Month which creates awareness about heart disease, the number one cause …